Glendon E. French III - Nov 14, 2022 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
President and CEO, Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Glendon E. French
Stock symbol
LUNG
Transactions as of
Nov 14, 2022
Transactions value $
$22,000
Form type
4
Date filed
11/14/2022, 07:04 PM
Previous filing
Sep 19, 2022
Next filing
Dec 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Options Exercise $22K +10K +0.97% $2.20* 1.04M Nov 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUNG Employee Stock Option (Right to Buy) Options Exercise $0 -10K -6.02% $0.00 156K Nov 14, 2022 Common Stock 10K $2.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on August 28, 2020, subject to the Reporting Person's continuous service through each such vesting date.